newsfilter
← Latest News
PR Newswire·

MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022

HUDDINGE, Sweden, Feb. 15, 2023 /PRNewswire/ -- Continued strong recruitment in the dose escalation part of the fostrox study. October – December Financial summary for the quarter Net turnover amounted to SEK 2.3 (13.9)